Significance of Angiogenesis in both Survival and Extermination (Via Treatment) Of the Tumour

Abstract

Angiogenesis is an essential process for development of blood vessels for growth and transport of the cancer cells. The following article enlightens the functionality of various drugs and therapies that aim for the treatment via pathways of regulation of angiogenesis and necrosis. Analysis and study of various drugs and therapies done by various researchers have been highlighted and exhibited along with their competency and failures listing few of which such as mesenchymal stem cells, Hybrid Liposomes (HL), angio-inhibitors and phytochemical isoliquiritigenin drugs, and also specific synthetic group of 25- OH Vitamin D to 1,25-OH Vitamin D [1,25(OH)2D] TNFα, protein drugs groups such as anti-VEGF antibodies and tyrosine kinase inhibitors, bevacizumab plus fluoropyrimidine-based chemotherapeutic drugs in inhibition of farnesyl diphosphate and various pathways in cancer treatment.

Keywords

Angiogenesis, Necrosis, Bevacizumab

Introduction

Cancer, today is one of the leading severe human disease that claim many lives across the globe, different countries around the world are in grip of different types of cancer based upon the biological as well as the abiotic and environmental factors [1]. Modern treatment methods applied into today’s oncology studies and treatment mostly revolve around cytotoxicity and cell induced necrosis of the cancer cells [2-5]. These methods have without any doubt provided effective results when viewed with respect to the cytotoxicity effect but on consideration of effect of the drug on overall systemic regulation of human body these drug tend to have side effect upon the non-targeted system or organ, hence the rise of the targeted drug delivery system as an leading base of research and study among the medical techniques cancer therapeutics. Angiogenesis is the process of development of new blood vessels and capillaries from the existing vessels through stimulated signaling pathways, it is generally the part of the repair mechanism that the body regulates for wound healing and repair, but as studies have shown that the cancer cells also take advantage of this regulation for them self and by overriding the control mechanism of the angiogenetic pathway tend to produce new blood vessels and capillaries for their supplies and transport. Treatment for the angiogenesis targeted therapy involve many potential methods such as mesenchymal stem cells, Hybrid Liposomes (HL), angio-inhibitors and phytochemical isoliquiritigenin harnessing the developmental pathways in tumor induced lymphangiogenesis and hematopoietic and endothelial progenitor cells cell-based therapies [6-10].

Angiogenesis

Cancer is one of the severe human diseases which cause increasing mortality every year in the world. Angiogenesis is the process of development of new blood vessels and capillaries from the existing vessels through stimulated signaling pathways, it is generally the part of the repair mechanism that the body regulates for wound healing and repair, but as studies have shown that the cancer cells also take advantage of this regulation for them self and by overriding the control mechanism of the angiogenetic pathway tend to produce new blood vessels and capillaries for their supplies and transport [11-14]. Malignant cells display metabolic changes, when compared to normal cells an impaired production of angiogenic molecule produced by ECs and pericytes seems to be involved in this dysfunctional angiogenesis and a deeper knowledge of this early pathogenic alteration of Hybrid liposomes (HL) that can be prepared by simply ultrasonicating a mixture of vesicular and micellar molecules in buffer solutions [15,16]. The theory behind the above includes the invagination of the tumor surface epithelium. The exposure of the invaginated epithelium to stimulation by hormones promotes its malignant transformation. Under pathological conditions however, blood vessels from the limbal vascular plexus could invade the cornea and adipose tissues which constantly growing in the adult organism and is one of the more actively remodeled tissues over the past decade, research investigating the development of the lymphatic vascular system has become a key focus within the fields of developmental biology and cancer biology [17-20].

The anti-mitotic effect of colchicine was exploited for the treatment of carcinomas as early as 1930’s considering that among the many cytokines accumulated in KS lesions, Fibroblast Growth Factor 2 (FGF-2 or basic FGF), plays an important role in the pathogenesis at the molecular level, pterygium has been reported as an overexpression of several growth factors related with cellular proliferation AAMP has a wide expression pattern, being observed in numerous endothelial and aortic smooth muscle cells, activated T-lymphocytes [21-26]. The tumor microvessel density of breast cancer is known to be predictive of bone marrow micro-metastases increased risk of mortality after cardiac injury, which was improved by E2 supplementation transplanted islet, and not from the host. Cultured islets were also shown to contain dedifferentiated endothelial cells not only due to chemical responses from tumor growth but also functional needs affect the capillary network structure induced by angiogenesis. Accelerating angiogenesis or anti-inflammatory effects and enhancing the therapeutic effects of the cell sheet that developed BPD, suggesting that bone marrow-derived endothelial progenitors may play a role in neonatal lung development. During tumor growth and neovasculrization in ocular tissues involves the stimulation by angiogenic factors [27-30].

Emerging evidences indicates that endothelial progenitor cells (EPC) may improve function of injured and ischemic organs prominent role of VEGF following PDT led to the advent of anti-VEGF therapy for neovascular eye diseases regulated by a fine balance between synthesis and degradation, but under pathological conditions, such as cancer cell expansion primarily by prolonging cell survival rather than by increasing the rate of cellular proliferation MAP kinase family members Erk-1 and Erk-2 influence VEGF expression thus, inhibition of them leads to lower expression of VEGF [31,32]. Unlike classically secreted proteins, unconventionally or nonclassically secreted polypeptides are devoid of signal peptides showing that mir126 identifiable group of endothelial-enriched miRNAs. Studies have focused on retinal neoangiogenetic factors in order to prevent one of the first steps of drug resistance, considering that VEGF-A is mainly produced and secreted by many tissue and immune cells like alveolar epithelial cells, bronchial epithelial cells, to be considered is the role and contribution that mesenchymal stem cells can do in the oncology once these cells have been investigated mainly focusing remodeling, angiogenesis and osteogenesis are closely associated processes [33-36]. Compelling evidence that vascular maintenance arises due mainly to two non-exclusive mechanisms primarily reflects their different content of proteoglycans of cytoplasmic granules this is thought to contribute to basement membrane thickening, impacting the proliferative and differentiated state of the endothelium VEGF which also acts as survival factor for endothelial cells and tumor cells and protect them from apoptosis of MM plasma cells, stromal cells, hematopoietic cells, and the extracellular matrix. Persistent neurogenesis occurs in two restricted regions of the adult mammalian brain including the human brainMany studies confirm that those capillaries are wide, dilated, tortuous and leaky these alterations would be more important proangiogenic growth factors and/or their receptors [37-40].

Using new natural and synthetic angiogenesis inhibitors, we might prevent or slow the growth of cancer myocardial remodeling are tightly linked, assuring appropriate dilatation of coronary vasculature is crucial biological processes of ALK activated transport and signal network in HCC compared with activated network of non-tumor hepatitis/cirrhotic tissues, it is believed that a point mutation at either of these positions may result in a change in secondary structure normalization of vascular architecture, hypoxic responses, tumor immune-reactivity and stem cell recruitment has only increased slightly and generally ranges between one and two years in spite of recent therapeutic advancements as for the modulate human TH-17 cells have been discussed intensely over the past few years [41-47]. Hypoxic endothelial cells were also explored to identify angiogenic factors in the ALDHbr cells that may express in ischemic tissues [48]. Chemokine receptors specially SDF-1/CXCR4 to breast cancer metastasis has been able to successfully inhibit the breast cancer metastasis, development and metastasis DMOG would increase antegrade collaterals through increased local levels of HIF-1 After the first application of IVB in OS, the patient was followed up for 200 weeks. Fifteen other intraocular injections were applied, Type IV collagen is ECM-specific and abundant collagen with various isoforms whose network assembly is essential for the structural integrity MVD is evaluated by antibodies against pan-endothelial cells, such as the anti-CD31, -CD34, or -von Willebrand factor antibodies [49,50].

Tissue Necrosis

Tumor/tissue necrosis study is aimed to establish a method for CEC detection in a critical care setting. We used human umbilical vein endothelial cells (HUVECs) Human body is composed of nearly 104 cells [51-54]. Every day billions of cells are produced by mitosis and a similar number of cells the infection myonecrosis virus (IMNV) and the infectious hypodermal and hematopoietic necrosis virus (IHHNV). Endocrine function of the kidney includes the conversion of 25- OH Vitamin D to 1,25-OH Vitamin D [1,25(OH)2D] TNFα is a potent pro-inflammatory cytokine and implicated in the pathogenesis of DR Childs can easily reach this region [55,56]. Foreign body in nose can be seen in children, mental retardation and psychiatric patients.Several studies on the step up approach in the management of infected pancreatic necrosis have been reportedlated envelope glycoproteins (or surface antigens). Within the envelope is the viral nucleocapsid, or core. Leishmania (Leishmania) infantum is the main etiologic agent of visceral leishmaniasis in American continentThe balance of proinlammatory and anti-inflammatory cytokines is essential for normal cellular functionWalled-off pancreatic necrosis (WOPN) is a serious complication that may ensue at least four weeks after an episode of acute pancreatitis [57-60].

All body organs are affected or are at risk to be affected by SCDAcute limb compartment syndrome (LCS) is a condition in which raised pressure within a closed fascial space reduces capillary perfusion Unfortunately, TNF-α blocking (TNFAB) therapy increases the risk for the development of active tuberculosis (TB) pancreatic pseudocyst secondary infection, histopathologic spectrum of lesions that can be divided into three stages multiple disease resistance imparted by the Yr18/ Lr34 locus, A CT scan or Magnetic Resonance Imaging (MRI) is essential prior to any intervention for a suspected pancreatic pseudocyst [61-66]. This necrotic pancreatic parenchyma and/or necrotic peripancreatic tissues is the site where WOPN derives and in time lesion could be infectedRecent efforts are focused on bacteria that synthesize NPs extracellularly or have used bacterial supernatants containing reductase enzymes hip in adults, the jaw in association with bisphosphonates, ON related to childhood onset conditions such as sickle cell anemia, applied teeth status before radiotherapy, dental treatment, among others [67,68]. With the conventional radiation techniquesCortical renal necrosis CRN is defined by a bilateral ischemic necrosis of the renal cortex without medullar lesion chemical structure of the bisphosphonates acts as a bone hook, allowing rapid and widespread distribution of bisphosphonates [69,70].

The sclerotic line seen radiographically correlates to a low signal line on T1 weighted MRI, which on T2 sequences demonstrates low signal with an adjacent hyperintense inner border known as the double line sign clear to auscultation [71]. Auscultation of his heart demonstrates normal sounds. the significance of this change is not clear. Radiographic response to therapies has been historically evaluated via the Response Evaluation Criteria in Solid Tumors (RECIST) Bisphosphonates may also contribute to an inhibition of bone resorption and an increase in bone mass [72-76]. Lesions induced by KA on cerebellar fastigial nucleus participates in the modulation of lymphocyte functions and that the hypothalamus and sympathetic nerves innervating cytokines and chemokines such transforming growth factor (TGF)- beta1, osteopontin, Tumor Necrosis Factor (TNF)-alphaThe extent of inflammatory disease was determined and ileocolitis was the most frequent type in CDIn order to establish mechanisms underlying the development of diabetic retinopathy and to determine whether cell death is crucial for the progression of the diseaseIn this context, the use of abciximab during RA has been shown to reduce procedural morbiditystimulates a protein that serves as a basis for the adrenocorticotropin hormone, which stimulates the adrenal gland cells to produce and release cortisol [77-80].

Tumor necrosis factor receptor superfamily member 11b, also known as osteoprotegerin (OPG), is a secreted glycoprotein belonging to the TNF receptor superfamily disease-specific cytokine balances by continuously measuring the levels of inflammatory cytokines (interleukin-6 [IL-6], interferon gamma [IFN-gamma], and tumor necrosis factor-alpha [TNF-alpha, TNF-a]) differentiation and inflammatory processes [81-83]. On the contrary, in other bones, BPs shows an inhibitory effect on osteoclast cell function. Monokines and lymphokines are crucial for induction of immune effector mechanisms against many pathogensTNF-alpha is overexpressed in skeletal muscle in dystrophic mdx mice and blockade of TNF-alpha reduced the adverse responses to exercise-induced muscle damagethe extent to which MSU or recombinant TNF-α (rhTNF-α) increased the frequency of apoptosis in human chondrocytes Tumour-associated DCs are often incapable of inducing specific cytotoxic immune responses, or can even induce regulatory T cell expansionWith increasing experience, knowledge of the epidemiology, possible risk factors, optimal diagnostic approach, and preventive measures has increasedherniated viscera remaining inside the abdominal cavity [84-88]. Predisposing factors for transomental hernias include congenital anatomic defects of the liver, lesser sac, mesenteryThe extravasation happens more in children and the elderly. The skin and vessels are fragile in the elderly and children have small vessels and they cannot express their pain, so these conditions bring more risk to them [89,90].

PDT is based on light-induced generation of a series of potentially cytotoxic reactive oxygen species (ROS) through photochemical reactions involving molecular oxygen. There was a statistically significant increase in total cholesterol and LDL-cholesterol levels in animals fed with cholesterol enriched diet compared with the control group (p <0.05) [91-96]. Current technology used for effluent blood water (EBW) disinfection at fish processing plants is largely dependent on mechanical and/or chemical processesChronic human immunodeficiency viral infection is characterized by defects in the immune system including depletion of CD4+ T-cells and impaired T-cell functionThe venom of Latrodectus contains a multitude of harmful proteinaceous and non-proteinaceous constituents which affect neuromuscular endplates and central nervous system synapses [97,98]. efforts are underway to develop new therapeutic agents and elucidation of metabolic pathway associated with diseases it becomes stunted with short internodes and proliferation of Axillary shoots. Petioles bearing fully expanded leaflets with initial symptoms become flaccid and droop. phthalmic examination was done including: assessing visual acuity, slit-lamp anterior and posterior segment biomicroscopy and IOP measurementsreoperatively, the HSS was compared in all patients at the final F/U. It was regulated as failure when the autologous BMT was converted into arthroplastyViral infection caused by nodaviruses belongs to nodaviridae family are common which causes viral nervous necrosis (VNN) [99,100].

Therapeutics

Proliferation and differentiation of osteoblast cells phytochemical examination of plants having suitable history of use in traditional treatment for diseases [101,102]. Molecular docking techniques have shown great promise as a new tool in the discovery of novel small molecule drugs for targeting angiogenic and anti-angiogenic therapies have been developed but their efficiencies have rarely met expectations optimization laboratory studies are warranted prior to initiating large-scale clinical trials of transplantation therapy for MI [103,104]. Major role of anti-angiogenic drugs is that the drug interferes with the angiogenic process via different mechanisms and there is a sound rationale for combining anti-angiogenic agents. Extensive studies conducted by a number of centers confirm the importance of angiogenesis and vasculogenesis in tumor development and the role of newly created pathological arterial perfusion although researchers initially focused on gene therapy using proangiogenic growth factors, recent discovery of somatic stem/progenitor cells the various histologic types of EOC have different responses to chemotherapy and have since known that they display divergent molecular characteristics , considering glioma which is a brain tumor that arises from glial cells or glial progenitor cells, and represents 80% of malignant brain tumor to evaluate the methods for the study of angiogenesis and lymph angiogenesis in GC and compare the results between three different microscopic magnifications, and describes its molecular mediators and discusses the interface between corneal lymph angiogenesis and adaptive immunity [105-110].

The therapeutic potential of adult stem cells for vascular regeneration has been further harnessed using transplantation strategies. In fact, experimentally enhancing or blocking lymph angiogenesis was shown to modulate the course of inflammatory and immune responses, physiological conditions include organ growth and development, wound healing and reproduction whereas pathologic conditions including tumor growth and metastasis inhibition of neo-angiogenesis as a new and attractive target for tumor therapy, since it theoretically offers the hope of long-term control of tumor progression [111-114]. Epidemiological studies have shown that atherosclerosis which can be initiated by a number of different conditions such as hypertension, diabetes, Hypertensive patients are at particular risk of cardiovascular complications, possibly related to endothelial damage or dysfunction or to abnormal angiogenesis in which the growth of nascent blood vessels from preexisting vessels, is a critically important process for both physiological (such as wound healing, reproduction and embryonic development) and pathophysiological conditions (such as solid tumor growth, the generation of new lymphatic vessels from preexisting ones in inflammatory diseases and cancer progression that are beginning to be elucidated [115-120].

Protein drugs groups such as anti-VEGF antibodies and tyrosine kinase inhibitors targeting VEGF receptors are now in clinical use for anti-angiogenic cancer therapy in pancreatic adenocarcinoma which is a leading cause of cancer death in the United States and represents a challenging chemotherapeutic problem due to migrated muscle cells that take up lipid droplets, proliferate and secrete fibrin, collagen and proteoglycans which make up a poorly developed extracellular matrix under pathologic conditions resulting in insufficient angiogenesis occurrence in diseases such as coronary artery disease, stroke, and chronic wounds such as Necrobiosis Lipoidica (NL) and Granuloma Annulare (GA) that belong to the granulomatous skin diseases with unclear pathogenesis [121-130].

Progression of disease is observed in colorectal cancer after use of the Bevacizumab plus fluoropyrimidine-based chemotherapy in cancer treatment in the setting of hypothyroidism, spontaneous or induced behaves differently than in euthyroidism, cells of individuals within a single species express surface polymorphic proteins known as major histocompatibility complex (MHC) antigens T3 and T4 trigger a non-genomic pathways through their binding to plasma membrane receptor have the best and ciliary body melanomas have the worst prognosis, both tumour cells and stromal cells such as fibroblasts and macrophages elaborate chemokines in the tumour microenvironment and the epithelium is exposed to a variety of environmental insults including complex aerosols regeneration with stem-cell transplantation which is a possible treatment option to reverse the deleterious hemodynamic and neurohormonal effects [131-140].

Glucocorticoid use is the most common cause of secondary osteoporosis and can lead to nontraumatic osteonecrosis. Treatment options for moderate to severe skin psoriasis have considerably progressed over the pastdecades with the widespread use of targeted biologicals including the patient response care such as the patient remains asymptomatic with no radiographic signs of pseudocyst recurrence. They interfere with the cholesterol biosynthesis pathway by inhibition of farnesyl diphosphate synthase there is no definitive treatment for BRONJ at this time, acute necrotizing pancreatitis, necrotic area or the presence of free gas in the pancreas on CECT [141-143]. An important issue was related to the exclusionERCP can provide information which is invaluable in managing chronic pancreatitisthat level of exposure to zoledronic acid has been identified as a significant risk factorLoss of bone mass may be slow, but once fractures start, other fractures follow, especially after minor accidents or fallscytologic detection of ECG obtained by fine-needle aspiration is useful for diagnosing unusual types of extrapulmonary tuberculosisIt was also reported that breast asymmetrical densities were present in approximately half of patients throughout the follow-up period of post-mammoplasty. Surgical treatment consists of the surgical removal of necrotic parts of the jawbone and, in most cases, safe and permanent mucosal coverage of former BRONJ sites, biopsy including thickened septa was performed to make a definitive diagnosis [144-150].

Conclusion

The above study gives us a moderate view of the types of drugs, medication and therapies such as the effects and the mode of treatment of mesenchymal stem cells, Hybrid Liposomes (HL), angio-inhibitors and phytochemical isoliquiritigenin drugs, and also specific synthetic group of 25- OH Vitamin D to 1,25-OH Vitamin D [1,25(OH)2D] TNFα, protein drugs groups such as anti-VEGF antibodies and tyrosine kinase inhibitors, bevacizumab plus fluoropyrimidine-based chemotherapeutic drugs in inhibition of farnesyl diphosphate and various pathways for the treatment of cancer for its different modes and kinds along with their effectiveness with respect to targeted delivery and cytotoxicity and also their failures as to the rise of various side effect from the frequent use, hence we can conclude that their exist many therapies and drugs that are and also will in future provide good response and effective treatment for the patients suffering with cancer provided their ability to recognize and target to specified locus and their also exist a scope in this angle for precision and development.

References

1. Kumar S, Ahmad MK, Waseem M, Pandey AK. Drug Targets for Cancer Treatment: An Overview. Med chem. 2015; 5:115-123
2. Benedetto PD, Liakouli V, Carubbi F, Ruscitti P, Berardicurti O, et al. Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Cocultured with Endothelial Cells. J Stem Cell Res Ther. 2015; 5: 265.
3. Ichihara H, Yamasaki S, Hino M, Ueoka R, Matsumoto Y. Hybrid Liposomes inhibit the Growth and Angiogenesis in Human Breast Cancer Model. J Carcinog Mutagen. 2015; 6:207.
4. Gavalas NG, Trachana SP, Dimopoulos MA, Bamias A. Angio-Inhibitors in Ovarian Cancer. J Cancer Sci Ther. 2014; 6:460-467.
5. Yang L, He W, Qu H, Jia C, Wang Y, et al. Phytochemical Isoliquiritigenin Inhibits Angiogenesis Ex Vivo and Corneal Neovascularization in Mice. Altern Integr Med. 2014; 3:176.
6. Lopatina T, Mazzeo A, Bruno S, Tetta C, Kalinina N, et al. The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor. J Stem Cell Res Ther. 2014; 4:245.
7. Francois M, Shayan R, Karnezis T. Ordered Chaos: Harnessing Developmental Pathways in Tumor-Induced Lymphangiogenesis. J Clin Cell Immunol. 2014; 5:270.
8. Denaro N, Russi EG, Merlano MC. Angiogenesis in Head and Neck Cancer. J Cancer Sci Ther. 2014; 6:455-459.
9. Otto W, Krol M, Maciaszczyk M, Najnigier B, Sierdzinski J, et al. Levels and Values of Circulating Hematopoietic and Endothelial Progenitor Cells in Patients with Hepatocellular Carcinoma . J Liver. 2014; 3:167.
10. Fujita Y, Kawamoto A. Cell-Based Therapies for Peripheral Arterial Disease. J Stem Cell Res Ther. 2014; 4:234.
11. Elit L, Hirte H. Novel Targeted Therapies in Ovarian Cancer. J Cancer Sci Ther. 2014; 6:350-362.
12. Ahmed AH, Sims M, Jones TS, Patil R, Patil S, et al. EDL-360: A Potential Novel Antiglioma Agent. J Cancer Sci Ther. 2014; 6:370-377.
13. Gresta LT, Júnior IAR, Cabral MMDÁ. Microvessel Density Quantification in Gastric Cancer: Comparing Methods for Standard Measures. J Cancer Sci Ther. 2014; 6: 401-405.
14. Chauhan SK, Dohlman TH, Dana R. Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity. J Clin Cell Immunol. 2014; 5:256
15. Seewoodhary J. Novel Approaches to Vasculopathies: The Role of Stem Cells and Regenerative Medicine. J Cardiovasc Dis Diagn 2: 166.Vranova M, Halin C (2014) Lymphatic Vessels in Inflammation. J Clin Cell Immunol. 2014; 5:250.
16. Xu G, Zhou Y, Zhang S, Ma S, Xu F, et al. Synthesis and Biological Evaluation N-(6,7-dimethoxynaphthalen-yl) sulfamide Derivatives as Novel Inhibitors of Angiogenesis and Tumor Growth. Med chem. 2014; 4:598-605.
17. Nakamura T, Suzuki Y, Takahashi Y, Satomi S, Sato Y. Paradoxical Augmentation of Tumor Angiogenesis Combined with Down-Regulation of IP-10 after Adenovirus-Mediated Transfer of Vasohibin-1 Gene in Cancer Cells. J Cancer Sci Ther. 2014; 6:289-297.
18. Patel A. Does the Role of Angiogenesis play a Role in Atherosclerosis and Plaque Instability?. Anat Physiol. 2014; 4:147.
19. karter Y. Oxidative Stress and Endothelial Dysfunction in White Coat Hypertension: Data of the Group from Cerrahpasa Medical Faculty. J Hypertens. 2014; 3:163
20. Feng X. Angiogenesis and Antiangiogenesis Therapies: Spear and Shield of Pharmacotherapy. J Pharma Care Health Sys. 2014; 1:e110
21. Onuigbo WIB. Lymphangiogenesis in Cancer: A Review. Biochem Physiol. 2014; 3:138.
22. Narbutt J, Kwiatkowska IS, Danilewicz M, Wozniacka A, Lesiak A. Impairment of Angiogenesis in Patients with Granuloma Annulare and Necrobiosis Lipoidica . J Clin Exp Dermatol Res. 2014; 5:226
23. Tangutoori S, Ohta A, Gatley S, Campbell RB. Repurposing an Erstwhile Cancer Drug: A Quantitative and Therapeutic Evaluation of Alternative Nanosystems for the Delivery of Colchicine to Solid Tumors. J Cancer Sci Ther. 2014; 6: 236-246.
24. Ray PE, Al-Attar A, Liu XH, Das JR, Tassi E, et al. Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma. J AIDS Clin Res. 2014; 5:309.
25. Godinez JGH, Benavides LG, Gonzalez SP, Cañaveral IIH, Gastelum FJG, et al. Effects of Nutritional Supplement with a-Lipoic Acid in Patients with Recurrent Pterygium. J Clin Exp Ophthalmol. 2014; 5:338
26. Yin Y, Sanders AJ, Feng L, Jiang WG. Knockdown of AAMP Impacts on HECV Cell Functions In Vitro and Affects the Expression of VECadherin. Angiol. 2014; 2:125.
27. Pistelli M, Ballatore Z, De Lisa M, Caramanti M, Pagliacci A. Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit?. Chemotherapy. 2014; 3:127
28. Mahmoodzadeh S, Leber J, Zhang X, Jaisser F, Messaoudi S, et al. Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction. J Cell Sci Ther. 2014; 5:153.
29. Sefidgar M, Soltani M, Bazmara H, Mousavi M, Bazargan M, et al. Interstitial Flow in Cancerous Tissue: Effect of Considering Remodeled Capillary Network. J Tissue Sci Eng. 2014; S4: 003
30. Shudo Y, Miyagawa S, Fukushima S, Kainuma S, Saito A, et al. Promising Therapeutic Effects of Cell Sheet Implantation with a Pedicle Omentum Flap to Enhance the Angiogenic Response to Ischemic Cardiomyopathy. J Stem Cell Res Ther. 2014; 4:159.
31. Bui KC, Kirzner J, George AA, Batra V, Payne KJ, et al. Circulating Endothelial Progenitors and Bone Marrow Derived Cells as Biomarkers for Risk of Bronchopulmonary Dysplasia. J Bone Marrow Res. 2014; 2:135.
32. Radisavljevic Z. Locus Chemotherapy in Cancer Angiogenesis. Biol Syst. 2013; 2:e106.
33. Davis PJ, Yalcin M, Lin HY, Tang HY, Hercbergs A, et al. Incomplete Success of Angioinhibitor Therapy in Cancer: Estimation of Contribution of Proangiogenic Activity of Patient Thyroid Hormone. J Cancer Sci Ther. 2013; 5:441-445.
34. Balzan S, Dell Carratore R, Nardulli C, Sabatino L, Lubrano V, et al. The Stimulative Effect of T3 and T4 on Human Myocardial Endothelial Cell Proliferation, Migration and Angiogenesis. J Clin Exp Cardiolog. 2013; 4:280.
35. Joanna R, Renata Z, Ewa PS, Lech C. The Significance of the Lymphocytes Infiltration and Endothelial-dependent Angiogenesis in Choroidal Melanomas. J Cytol Histol. 2013; 4:200.
36. Gunda V, Sudhakar YA. Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors. J Cancer Sci Ther. 2013; 5:417-426.
37. Qazi Y, Hamrah P. Corneal Allograft Rejection: Immunopathogenesis to Therapeutics. J Clin Cell Immunol. 2013; S9: 006.
38. Bogoslovsky T, Wang D, Maric D, Scattergood-Keepper L, Spatz M, et al. Cryopreservation and Enumeration of Human Endothelial Progenitor and Endothelial Cells for Clinical Trials. J Blood Disorders Transf. 2013; 4:158.
39. Nowak-Sliwinska P, Weiss A, Sickenberg M, Griffioen AW, van den Bergh H. The Role of Photodynamic Therapy in Non-malignant and Malignant Eye Disorders. J Anal Bioanal Tech. 2013; S1:007
40. Pivetta E, Colombatti A, Spessotto P. A Rare Bird among Major Extracellular Matrix Proteins: EMILIN1 and the Tumor Suppressor Function. J Carcinogene Mutagene. 2013; S13:009.
41. Kaur H, Gupta S. An Analysis of the Expression of Bcl-2, Podoplanin and Lymph Angiogenesis in Benign and Malignant Salivary Gland Tumours. J Clin Exp Pathol. 2013; 3:145.
42. Kadioglu O, Seo EJ, Efferth T. Targeting Angiogenesis By Phytochemicals. Med Aromat Plants. 2013; 2:134.
43. Prudovsky I. Nonclassically Secreted Regulators of Angiogenesis. Angiol. 2013; 1:101.
44. Lee CH, Chae JI, Ko HY, Kim S. Molecular Beacon-Based Microrna Biosensor for Imaging EPC-Treated Cellular Therapy of Ischemia. J Mol Imaging Dynam. 2013; 3:113.
45. Semeraro F, Cancarini A, Forbice E, Morescalchi F, Donati S, et al. Erythropoietin and Diabetic Retinopathy. J Diabetes Metab. 2013; 4:283.
46. Meyer N. IL-32, a Negative Regulator of Angiogenesis in Chronic Airway Diseases. J Vasc Med Surg. 2013; 1:e111.
47. Rici REG, Will SEA, Favaron PO, Fratini P, Miglino MA, et al. Modulation of Angiogenesis and Immune Response in Canine Osteosarcoma by BMP-2 and Mesenchymal Stem Cells. J Stem Cell Res Ther. 2013; 3:143.
48. Fratini P, Alcântara D, Rodrigues MN, de Oliveira e Silva FM, et al. Osteogenesis in Chicken (Gallus gallus domesticus) and Expression of VEGF in this Process between 5° to 19° Days of Incubation. J Cytol Histol. 2013; 4:178
49. Manjamalai A, Grace B. Chemotherapeutic Effect of Essential Oil of Wedelia chinensis (Osbeck) on Inducing Apoptosis, Suppressing Angiogenesis and Lung Metastasis in C57BL/6 Mice Model. J Cancer Sci Ther. 2013; 5:271-281.
50. Hanane B, Abdelouahab C, Abderrahmane B, Amina M, Soulef HK, et . Research of New Molecules Able to Starve the Tumors by Molecular Docking's Method. Biochem Pharmacol. 2013; 2:117.
51. De Rossi G, Scotland RS, Whiteford JR. Critical Factors in Measuring Angiogenesis Using the Aortic Ring Model. J Genet Syndr Gene Ther. 2013; 4:147.
52. Acosta SA, Franzese N, Staples M, Weinbren NL, Babilonia M, et al. Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction. J Stem Cell Res Ther. 2013; S4:005.
53. Roura S, Bagó JR, Montón CG, Blanco J, Genis AB. In Vitro Characterization of the Molecular Machinery Regulating Umbilical Cord Blood Mesenchymal Stem Cell Angiogenesis: A Step Towards Multipotent Stem Cell Therapy for Vascular Regeneration. J Stem Cell Res Ther. 2013; 3:140.
54. Crivellato E, Ribatti D. Cooperation of Mast Cells and Basophils in Allergy. J Allergy Ther. 2013; 4:135.
55. Sorenson CM, Wang S, Gendron R, Paradis H, Sheibani N. Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy. J Diabetes Metab. 2013; S12:005.
56. Arun Kumar M, Nisha Kumari O, Abhimanyu Kumar. Prospective Role of Indian Medicinal Plants in Inhibiting Vascular Endothelial Growth Factor (VEGF) mediated Pathological Angiogenesis. J Homeop Ayurv Med. 2013; 2:121.
57. Ria R, Berardi S, Reale A, Luisi AD, Catacchio I, et al. Multiple Myeloma: The Role of Angiogenesis in Disease Progression. J Bone Marrow Res. 2013; 1:117
58. Yamashita T, Abe K. Endogenous Neurogenesis, Oligodendrogenesis and Angiogenesis after Ischemic Brain Injury. J Neurol Neurophysiol. 2013; S8:003.
59. El Aggan HA, Helmy MA, El Deeb NMF, Zeid AE, Yehia MFA. Macrophage Inflammatory Protein-1a (MIP-1 a) in Hepatitis C Virus-Related Hepatocellular Carcinoma: Relation to Clinical Staging and Tumour Angiogenesis. J Clin Exp Pathol. 2012; 3:133.
60. Park JS, Schlage WK, Frushour BP, Talikka M, et al. Construction of a Computable Network Model of Tissue Repair and Angiogenesis in the Lung. J Clinic Toxicol. 2013; S12:002.
61. Hassan AUl, Hassan G, Rasool Z, Muneeb. Stem Cell Therapy in Myocardial Infarction: Latest Trends. J Cytol Histol. 2012; 3:162.
62. Guérard S, Pouliot R. The Role of Angiogenesis in the Pathogenesis of Psoriasis: Mechanisms and Clinical Implications. J Clin Exp Dermatol Res. 2012; S2:007.
63. Malki AM. Angiogenesis and Antiangiogenic Therapy: Revisited. J Genet Syndr Gene Ther. 2012; 3:e116.
64. Huang W, Millard RW, Wang Y. Stem Cell Therapy for Endothelial Dysfunction in the Coronary Circulation. Autacoids. 2011; S3-001.
65. Wang L, Huang J, Lin H. ALK Folic Acid Transport and Integrin Signal Induced-Angiogenesis Network in Human Hepatocellular Carcinoma (HCC) by Systems-Theoretical Analysis. Molecular Biology. 2012; 1:102.
66. Volk AL, Johns L, Beck H, McCabe FL, Rafferty P, et al. Tissue Factor (TF) Expression and Angiogenesis in Tumor Progression and Inhibition of Tumor Growth by Anti-TF Antibodies in Human Tissue Factor Knock-In Mice. J Carcinogene Mutagene. 2012; S7:001.
67. French KJ, Frazier KS. The Role of VEGF and VEGF Receptors in Carcinogenesis. J Carcinogene Mutagene. 2011; S2:002.
68. Kaminska B, Gabrusiewicz K, Sielska M. Characteristics of Phenotype and Pro-Tumorigenic Roles of Glioma Infiltrating Microglia/Macrophages. J Neurol Neurophysiol. 2011; S5.
69. Volin MV, Shahrara S. Role of TH-17 Cells in Rheumatic and Other Autoimmune Diseases. Rheumatology. 2011; 1:104.
70. White HS, Smith L, Gentry T, Balber AE. Mechanisms of Action of Human Aldehyde Dehydrogenase Bright Cells in Therapy of Cardiovascular Diseases: Expression Analysis of Angiogenic Factors and Aldehyde Dehydrogenase Isozymes. J Stem Cell Res Ther. 2011; S1:001.
71. Razmkhah M, Jaberipour M, Ghaderi A. Chemokines and Chemokine Receptors Expression in the Adipose Derived Stem Cells (ASCs), Breast Tissues and in Peripheral Blood of Patients with Breast Cancer. J Carcinogene Mutagene. 2011; 2:120
72. Oliveira JP, Magliarelli HF, Pereira FV, Gianotti A, Soares-Costa A, et al. Sugarcane cystatin CaneCPI-4 inhibits Melanoma Growth by Angiogenesis Disruption. J Cancer Sci Ther. 2011; 3: 161-167.
73. Kelly DJ, Morton AC, Arnold ND, Mecinovic J, Schofield C, et al. Activation of Hypoxia-Inducible Factor by Di-Methyl Oxalyl Glycine (DMOG) Increases Neovascularization within Ischaemic Myocardium in a Porcine Coronary Artery Occlusion Model. J Clinic Experiment Cardiol. 2011; 2:148.
74. Paula JS, Shinsato RN, Queiroz WS, Ribeiro JAS, Jorge R. Longterm Intraocular Pressure Control in a Case of Neovascular Glaucoma Treated with Repeated Intravitreal Bevacizumab Injections. J Clinic Experiment Ophthalmol. 2011; 2:170.
75. Shah D, Nandakumar S, Jaishankar GB, Chilakala S, Wang K, et al. Pre-Term Exposure Patterns in Neonatal Intensive Care Unit Alters Immunological Outcome in Neonates. J Aller Ther. 2011; 2:106.
76. Sarrazin S, Maurage CA, Delmas D, Lassalle P, Delehedde M. Endocan as a Biomarker of Endothelial Dysfunction in Cancer. J Cancer Sci Ther. 2010; 2: 047-052
77. Sri Devi M, Vinothini K, Veronica Shalini, Krishnamoorthy Masilamani, Dharini Sivakumar, Arjun Pandian. Angiosuppresive activity of Leucas aspera (Willd) Linn. using Chicken Chorioallantoic Membrane (CAM) assay. IJIRSET. 2013; 2: 6327-6333
78. Muhammad Wasif Saif. Anti-Angiogenesis Therapy in Pancreatic Carcinoma. J Pancreas. 2006; 7(2):163-173.
79. Linda Tillmar, Nils Welsh.  In Vitro Cultured Rat Islets Express Genes That both Prevent and Promote Angiogenesis . J Pancreas. 2004; 5(2):81-91.
80. Tamura A, Hebisawa A, Shimada M, Suzuki J, Yamane A, et al. Epithelioid Cell Granuloma Detection in the Sputum of Patients with Pulmonary Tuberculosis. J Mycobac Dis. 2014; 4: 158.
81. Touyz LZG. Osteoporosis and Oral Implications. J Osteopor Phys Act. 2014; 2:119.
82. Shen LK, Lin SL, Choy CS, Chan WP, Gasbarri M, et al. Using Breast MRI to Evaluate Complications of Autologous Fat Grafting. Surgery Curr Res. 2014; 4:197.
83. Echols K, Fang F, Patterson JW. A Review of Lupus Miliaris Disseminatus Faciei-Like Histopathologic Changes in 10 Cases. J Clin Exp Dermatol Res. 2014; 5:223.
84. Shah SJA, Hussain S, Ahmad M, Farhatullah, Ibrahim M. Characterization of Slow Rusting Resistance against Puccinia striiformis f. sp. tritici in Candidate and Released Bread Wheat Cultivars of Pakistan. J Plant Pathol Microb. 2014; 5:223.
85. Goyal J. Peripancreatic Fluid Collections: A Review. Pancreat Disord Ther. 2014; 4:131
86. Turkoglu MA, Cifci K, Vural V, Erbis H, Dogru V, et al. Surgical Management of Giant Walled-off Necrosis. Surgery Curr Res. 2014; 4: 190.
87. Sonkusre P, Nanduri R, Gupta P, Cameotra SS. Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and their Specificity for Cancer Chemoprevention. J Nanomed Nanotechnol. 2014; 5:194.
88. Jick S, Li L. Risk of Osteonecrosis among Persons with Osteoarthritis of the Knee: Findings from the UK based General Practice Research Database. Orthopedic Muscul Sys. 2014; S2:002.
89. Stramandinoli-Zanicotti RT, Silva WPP, Schussel JL, Dissenha JL, Sassi LM. Pathological Fracture of the Mandible Associated to Osteoradionecrosis with Necrotic Bone and Reconstruction Plate Exposure: Case Report. Dentistry. 2014; S2:002.
90. Sahbaz T, Javadov A, Diraçoglu D. A Case of Glucocorticoid-Induced Multifocal Osteonecrosis. J Nov Physiother. 2015; 5:250.
91. Piérard GE, Hermanns-Lê T, Piérard-Franchimont C, Piérard SL. Analytical Assessment of TNF-Antagonist Early Effects on Psoriasis: In Vivo Real-time Reflectance Confocal Microscopy and Skin Capacitance Mapping. J Med Diagn Meth. 2014; 3:165
92. Tochikubo J, Matsuda N, Ota Y, Higashi T, Takatani Y, et al. Detection of Inflammatory Circulating Endothelial Cells Using Human Umbilical Vein Endothelial Cells Detached from Culture Dishes by Tumor Necrosis Factor-alpha as Control Cells. Cardiol Pharmacol. 2015; 4:129
93. Jayakiran M. Apoptosis-Biochemistry: A Mini Review. J Clin Exp Pathol. 2015; 5:205.
94. Vieira-Girão PRN, Rocha IRCB, Gazzieno M, Vieira PRN, Lucena HMR, et al. Low Salinity Facilitates the Replication of Infectious Myonecrosis Virus and Viral Co-Infection in the Shrimp Litopenaeus Vannamei. J Aquac Res Development. 2015; 6:302.
95. Vijayan A, Li T, Dusso A, Jain S, Coyne DW. Relationship of 1,25 dihydroxy Vitamin D Levels to Clinical Outcomes in Critically Ill Patients with Acute Kidney Injury. J Nephrol Ther. 2015; 5:190.
96. Huang H, Li W, He J, Barnabie P, Shealy D, et al. Blockade of Tumor Necrosis Factor Alpha Prevents Complications of Diabetic Retinopathy. J Clin Exp Ophthalmol. 2014; 5:384.
97. Sahin C. Nasal Mucosa Necrosis Against Alkaline Battery Foreign Body. J Clin Case Rep. 2014; 4:444.
98. Georgin-lavialle S, Lafont E, Stansal A, Pouchot J. Digital Necrosis in Type I Cryoglobulinemia. J Blood Lymph. 2014; 4:i102.
99. Machado NO, Machado NN. “Step Up” Approach in the Management of Pancreatic Necrosis. Is it A Step in the Right Direction?. Pancreat Disord Ther. 2014; 4:e136.
100. Nobili L, Albani L, Gabrielli A, Moroncini G. Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-a Therapy. J Antivir Antiretrovir. 2014; 6:092-101.
101. Aquino TA, Martins SS, Gomes CM, Carneiro da Motta JO, Graziani D, et al. First Case Report of Cutaneous Leishmaniasis Caused by Leishmania (Leishmania) infantum in a Brazilian Patient Treated with Adalimumab. J Clin Exp Dermatol Res. 2014; 5:245.
102. Saxena M, Modi DR. Inflammation and Diabetes. Microinflammation. 2014; 1:110.
103. Ballas SK, Lobo CLDC, Cavalcanti WE. Dental Complications of Sickle Cell Disease. J Interdiscipl Med Dent Sci. 2014; 2:152.
104. May J, Macfarlane R, Sadri A. Acute Skin Necrosis with Compartment Syndrome in the Upper Extremity. Anat Physiol. 2014; 4:161.
105. Birkenkamp KE, Lauzardo M, Mangura BT, Brito MO, Griffith DE, et al. Diagnosis and Management of Tuberculosis in Candidates for Tumor Necrosis Factor Alpha Antagonists: An Experts Survey. J Mycobac Dis. 2014; 4:171.
106. Rodrigo Azevedo Rodrigues, Lucianna Pereira da Motta Pires Correia, Maria Rachel da Silveira Rohr, Frank Shigueo Nakao, Marcus Melo Martins dos Santos et al. Endoscopic Resolution of Pseudocyst Infection and Necrosis as a Complication of Endoscopic Pseudocyst Drainage. A Case Report. J Pancrea. 2008; s 9:499-503
107. Muhammad Wasif Saif. Management of Bisphosphonate-Related Osteonecrosis of the Jaw. J Pancreas. 2009; 10:581-582.
108. Mustafa Erkan, Oguz Bilgi, Mesut Mutluoglu, Günalp Uzun. Bisphosphonate-Related Osteonecrosis of the Jaw in Cancer Patients and Hyperbaric Oxygen Therapy. J Pancreas. 2009; 10:579-580.
109. Generoso Uomo. Nonsurgical Treatment of Infected Pancreatic Necrosis:A Falling Myth or a Still Impassable Frontier?. J Pancreas. 2007; 8:468-470.
110. Velayutham Vimalraj, Satyanesan Jeswanth, Devy Gounder Kannan, Colonel S Krishnan, Rajagopal Surendran. Acute Portal Vein Thrombosis and Massive Necrosis of the Liver. An Unusual Complication after Stenting for Chronic Pancreatitis. J Pancreas. 2006; 7:660-664.
111. Cisse MM, Ka EF, Seck SM, Dial CM, Diouf AA, et al. Obstetric Cortical Renal Necrosis, Even Reality in the Tropics. J Nephrol Ther. 2014; 4:156.
112. Iwamoto J. Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis. Pharm Anal Acta. 2014; 5:285.
113. Ricardo Ochoa E, Sakin C, Madhoun H, Rogers AD, Jarjour WN. Avascular Necrosis of the Spine in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Rheumatology. 2013; 4:127.
114. Elcioglu OC, Ozkok A, Bakan A, Ozluk Y, Kilicaslan I, et al. Phenyramidol Induced Acute Tubular Necrosis. J Nephrol Ther. 2014; 4:152.
115. Bedi M, Kharofa J, Zambrano EV, Chang J, Baynes K, et al. Tumor Increase on MRI after Neoadjuvant Treatment is Associated with Greater Pathologic Necrosis and Poor Survival in Patients with Soft Tissue Sarcoma. J Integr Oncol. 2013; 2:109.
116. Famili P. Oral Bisphosphonates and Relationship to ONJ and Dental Implants. Dentistry. 2013; 4:188.
117. Sekerci AE, Sahman H, Ulu M, Etoz OA, Sisman Y. Bisphosphonate-related Osteonecrosis of the Jaws: Report of Two Cases with Breast Cancer, a Dental Concern and review of the Literature. Biodiscovery 2012; 1: 2.
118. Gayathri V, Mohanan PV. Protective Mechanism of Melatonin on Kainic Acid Induced Immune Modulatory Effect on Lymphocytes Derived from Mouse Spleen. J Clin Cell Immunol. 2013; 4:172.
119. Meliambro K, He JC, Campbell KN. The Podocyte as a Therapeutic Target in Proteinuric Kidney Disease. J Nephrol Ther. 2013; 3:143.
120. Nascimento J, Antunes H. Inflammatory Bowel Disease-Experience of a Pediatric Gastroenterology Unit. Pediat Therapeut. 2013; 3:173.
121. Feenstra DJ, Yego EC, Mohr S. Modes of Retinal Cell Death in Diabetic Retinopathy. J Clin Exp Ophthalmol. 2013; 4:298.
122. García-Lara J, Pinar-Bermúdez E, Lacunza-Ruiz J, Valdesuso-Aguilar R, Hurtado JA, et al. Lack of Peri-Procedural Myocardial Necrosis Reduction from Abciximab in Patients on Dual Antiplatelet Therapy Revascularized with Rotational Atherectomy. J Clin Exp Cardiolog. 2013; 4:270.
123. Hernández MV, Vidal S, Sanmarti R. Analysis of the Mechanism of Action of Biological Therapies in Monotherapy in Patients with Rheumatoid Arthritis: Beyond the ADACTA Study. Adv Pharmacoepidemiol Drug Saf. 2013; 2:141.
124. Rugani P, Truschnegg A, Acham S, Kirnbauer B, Jakse N. Use of Photodynamic Therapy in Treatment of Bisphosphonate-related Osteonecrosis of the Jaws: Literature Review and Case Series. J Anal Bioanal Tech. 2013; S1:006.
125. Nakamura Y, Fujisawa Y, Obara S, Saito A, Nakamura Y, et al. Giant Lipoma with Fat Necrosis of the Back Mimicking Atypical Lipomatous Tumor in MRI Findings. J Clin Exp Dermatol Res. 2013; S6:013.
126. Cheng KW, Agarwal R, Mitra S, Mills G. Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAIL. J Genet Syndr Gene Ther. 2013; 4:153.
127. Nakamura S, Takeda K, Hashimoto Y, Mizumoto T, Iizuka H, et al. Levels of Tumor Necrosis Factor-Alpha, Interleukin-6, and Interferon-Gamma during the Active Phases of Bechet’s Disease, Pustular Psoriasis, Palmoplantar Pustulosis, and Stevens-Johnson Syndrome: A Pilot Study. J Clin Exp Dermatol Res. 2013; 4:175.
128. Mozzati M, Gallesio G, Pol R, Muzio G, Canuto R, et al. A Report on a 7-year Follow up of the Surgical Management with PRGF®-ENDORET® of Oncologic Patients Affected by Intravenous Bisphosphonate Related Osteonecrosis of the Jaw. Surgery. 2013; S12:011.
129. Achidi EA, Apinjoh TO, Yafi CN, Besingi R, Anchang JK, et al. Plasma Levels of Tumour Necrosis Factor-Alpha, Interleukin-10, Interleukin-12, Macrophage Inhibition Factor and Transforming Growth Factor-Beta in Children with Severe and Uncomplicated Falciparum Malaria. J Trop Dis. 2013; 1:103.
130. Renstram L, Song Y, Stål PS, Forsgren S. TNF-alpha in an Overuse Muscle Model–Relationship to Muscle Fiber Necrosis/Regeneration, the NK-1 Receptor and an Occurrence of Bilateral Involvement. J Clin Cell Immunol. 2013; 4:138.
131. Cheng KW, Agarwal R, Mitra S, Mills GB. Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAIL. J Genet Syndr Gene Ther. 2013; 4:153.
132. Nakamura S, Takeda K, Hashimoto Y, Mizumoto T, Iizuka H, et al. Levels of Tumor Necrosis Factor-Alpha, Interleukin-6, and Interferon-Gamma during the Active Phases of Bechets Disease, Pustular Psoriasis, Palmoplantar Pustulosis, and Stevens-Johnson Syndrome: A Pilot Study. J Clin Exp Dermatol Res. 2013; 4:175.
133. Mozzati M, Gallesio G, Pol R, Muzio G, Canuto R, et al. A Report on a 7-year Follow up of the Surgical Management with PRGF®-ENDORET® of Oncologic Patients Affected by Intravenous Bisphosphonate Related Osteonecrosis of the Jaw. Surgery. 2013; S12:011.
134. Achidi EA, Apinjoh TO, Yafi CN, Besingi R, Anchang JK, et al. Plasma Levels of Tumour Necrosis Factor-Alpha, Interleukin-10, Interleukin-12, Macrophage Inhibition Factor and Transforming Growth Factor-Beta in Children with Severe and Uncomplicated Falciparum Malaria. J Trop Dis. 2013; 1:103.
135. Renstram L, Song Y, Stal PS, Forsgren S. TNF-alpha in an Overuse Muscle Model–Relationship to Muscle Fiber Necrosis/Regeneration, the NK-1 Receptor and an Occurrence of Bilateral Involvement. J Clin Cell Immunol. 2013; 4:138.
136. Malemud CJ, Sun Y, Pearlman E, Ginley NM, Awadallah A, et al. Monosodium Urate and Tumor Necrosis Factor-a Increase Apoptosis in Human Chondrocyte Cultures. Rheumatol Curr Res. 2012; 2:113.
137. Lotfi R, Wiegmann DS, Asseck L, Erle A, Yildiz T, et al. Necrosis- Associated Factors (DAMPs) Including S100A4 Used to Pulse Dendritic Cells (DCs) Induce Regulatory T cells. J Cell Sci Ther. 2012; 3:134.
138. Jacobsen C, Zemann W, Obwegeser JA, Seifert B, Gratz KW, et al. Treatment of Osteopathology of the Jaws Associated with Bone Resorption Inhibitors: An 8-Year Single-Centre Experience. Dentistry. 2012; 2:146.
139. Furukawa S, Wingenfeld L, Sakaguchi I, Nakagawa T, Takaya A, et al. (2012) Strangulated Transomental Hernia with Intestinal Necrosis: An Autopsy Case. J Forensic Res 3:163.
140. Kim YH, Kim YD (2012) A Case of Skin Necrosis after Extravasation of Intravenous Immunoglobulin. Pediat Therapeut 2:136.
141. Figueiró Longo JP, Muehlmann LA, Velloso NV, Simioni AR, Lozzi SP, et al. Effects of Photodynamic Therapy Mediated by Liposomal Aluminumphthalocyanine Chloride on Chemically Induced Tongue Tumors. Chemotherapy. 2012; 1:103.
142. Ren Y, Cai Y, Jia D. KB-R7943 Reduces Necrosis and Apoptosis in Hyperlipidemic Animals through the Activation of K+ATP Channels. J Clinic Experiment Cardiol. 2011; S5:001
143. Afonso LO, Richmond Z, Eaves AA, Richard J, Hawley LM, et al. Use of Ultraviolet C (UVC) Radiation to Inactivate Infectious Hematopoietic Necrosis Virus (IHNV) and Viral Hemorrhagic Septicemia Virus (VHSV) in Fish Processing Plant Effluent. J Aquac Res Development. 2012; 3:120
144. Hima Bindu A, Naga Anusha P. Adverse Effects of Highly Active Anti-Retroviral Therapy (HAART). J Antivir Antiretrovir. 2011; 3: 060-064.
145. Ahrens B, Crocker C. Bacterial Etiology of Necrotic Arachnidism in Black Widow Spider Bites. J Clinic Toxicol. 2011; 1:106.
146. Pillai L, Pant B, Chauhan U, Pardasani KR. SVM Model for Amino Acid Composition Based Prediction of Mycobacterium tuberculosis. J Comput Sci Syst Biol. 2011; 4: 047-049
147. Gomase VS, Kale KV, Shyamkumar K. Prediction of MHC Binding Peptides and Epitopes from Groundnut Bud Necrosis Virus (GBNV). J Proteomics Bioinform. 2008; 1: 188-205.
148. Ghanem AA, Arafa LF, Elewa AM. Tumor Necrosis Factor-a and Interleukin-6 Levels in Patients with Primary Open-Angle Glaucoma. J Clinic Experiment Ophthalmol. 2011; 2:118.
149. Hwang J, Lee S, Park H, Kim M. Autologous Bone Marrow Transplantation in Osteonecrosis of the Femoral Head. J Tissue Sci Eng. 2011; 2:103
150. Krishnan K, Khanna VG, Hameed S. Antiviral Activity of Dasyscyphin C Extracted from Eclipta Prostrata Against Fish Nodavirus. J Antivir Antiretrovir. 2010; 1: 029-032.